About
Arnon Rosenthal is an Israeli-American neuroscientist, biotech entrepreneur, and company founder focused on neurodegeneration and neuroimmunology. He has served as co-founder, chief executive officer, and director of Alector since 2013, and previously co-founded Annexon Biosciences and Rinat Neuroscience. Earlier in his career he held senior scientific roles at Genentech, where his team discovered the target for the cancer drug Erivedge, according to Alector.
Areas of interest
biotechneuroscienceneurodegenerationneuroimmunologyAlzheimer's diseaseParkinson's diseasefrontotemporal dementiaimmunologyantibody therapeuticsautoimmune disease